RESOURCES

Clinical trial transparency, in depth.

Practical guides for the teams doing the work — clinical trial anonymization and redaction, defensible AI in medical writing, and the build-vs-buy decisions behind a GenAI program.

Get a demo

Who these guides are for

Practitioners doing the work: transparency and disclosure leads, medical writers, and the privacy and compliance people who sign off on a release. They cover anonymization method and risk, AI in regulatory writing, and the mechanics of specific obligations — at more depth than a page of the site can carry. Some are gated and some are not; where a guide maps to a live obligation like EMA Policy 0070 or Health Canada PRCI, the matching solutions page gives you the deadlines and citations first.

Start with the clinical trial anonymization whitepaper

 Anonymization The Ultimate Guide to Anonymization or Redaction A risk-based playbook for disclosing clinical documents without exposing patients or trade secrets — the strategy, the workflow, and the mindset behind confident anonymization.
  • 8 pages
  • 14 min read
  • PDF
Get the whitepaper
Medical Writing Transforming Medical Writing with AI A practical handbook for regulatory, clinical, and medical writing teams putting AI to work in real document workflows.
  • 12 pages
  • PDF
Get the whitepaper
GenAI GenAI That Works in Pharma Why build-vs-buy is the GenAI decision that quietly makes or breaks your AI program — and how partnerships outperform internal builds in…
  • 5 pages
  • 7 min read
  • PDF
Get the whitepaper

Prefer a conversation to a PDF?

Get a demo

Talk with a TrialAssure expert about the requirement you are working through.

Transparent Thinking

Regulatory changes, before they bite

Deadlines, rule changes and practical guidance on clinical trial transparency, in your inbox. No noise.

Subscribe